GlassScriptPhysician profile
Leon K Liem
NPI 1639106933
$9,259.74
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,921 · 2020: $338.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,358.87 | 2019 | |
| Medtronic USA, INC. | $2,125.91 | 2019-2020 | |
| Irras USA, INC. | $941.57 | 2019 | |
| Nuvasive, INC. | $840.41 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $264.15 | 2019-2020 | |
| Boston Scientific Corporation | $127.47 | 2020 | |
| Mallinckrodt Enterprises LLC | $96.53 | 2019 | |
| Genzyme Corporation | $94.16 | 2019 | |
| Osteomed LLC | $73.64 | 2019 | |
| Stryker Corporation | $62.06 | 2019 | |
| Emd Serono, INC. | $49.89 | 2019-2020 | |
| Ethicon US, LLC | $43.57 | 2019 | |
| Ucb, INC. | $43.38 | 2019 | |
| Neuropace, INC. | $41.66 | 2019 | |
| Monteris Medical Corporation | $35.22 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $26.18 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.01 | 2020 | |
| Acorda Therapeutics, INC | $15.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Liem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.